{"disease":{"id":"egfrmutant-stage-iiib-c-or-iv-non-squamous-nsclc","name":"egfrmutant stage iiib c or iv non squamous nsclc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04245085","title":"ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"ETOP IBCSG Partners Foundation","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}